Wuhan Hysen Biotech Co., Ltd.
2026 Semi-Annual Report
2026-066
August 2026
Section I Important Notices, Table of Contents, and Definitions
The Board of Directors, the Board of Supervisors, and the directors, supervisors, and senior management of the Company guarantee that the information in this semi-annual report is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions, and they assume individual and joint legal liability.
Company head Zhang Weiyuan, person in charge of accounting Yang Kaijie, and head of the accounting department (accounting supervisor) Luo Qiongbi declare: We guarantee the truth, accuracy, and completeness of the financial reports in this semi-annual report.
All directors attended the board meeting to review this semi-annual report.
Forward-looking statements in this semi-annual report, such as future plans or projections, do not constitute substantive commitments by the Company to investors. Investors and relevant parties should maintain sufficient risk awareness and understand the differences between plans, forecasts, and commitments.
The Company faces risks including cyclical fluctuations in downstream industries, significant volatility in raw material prices, risks associated with overseas market expansion, and accounts receivable recovery risks. Investors are advised to be aware of investment risks. For details, please refer to Section III "Management Discussion and Analysis" under "X. Risks Faced by the Company and Countermeasures."
The profit distribution plan approved by the Board of Directors is as follows: Based on the Company's current total share capital of 201,784,357 shares, after deducting 1,370,900 repurchased shares, the base for distribution is 200,413,457 shares. The Company will pay a cash dividend of 3.00 yuan (tax included) for every 10 shares to all shareholders, issue 0 bonus shares (tax included), and will not increase share capital from the capital reserve.
Table of Contents
Section I Important Notices, Table of Contents, and Definitions 1
Section II Company Profile and Key Financial Indicators 5
Section III Management Discussion and Analysis 9
Section IV Corporate Governance, Environment, and Social Responsibility 33
Section V Important Matters 37
Section VI Changes in Shares and Shareholders 44
Section VII Information on Bonds 49
Section VIII Financial Report 50
List of Documents Available for Inspection
(I) Financial statements signed and stamped by the Company head, the person in charge of accounting, and the head of the accounting department (accounting supervisor).
(II) Originals of all company documents and announcements publicly disclosed on the website designated by the CSRC during the reporting period.
(III) The original copy of the 2026 semi-annual report signed by the Chairman and stamped by the Company.
(IV) Location for the above documents: Securities Affairs Department of the Company.
Definitions